KWM
XRTX

Kingsview Wealth Management’s XORTX Therapeutics XRTX Stock Holding History

Kingsview Wealth Management’s Portfolio XRTX Stock Details XRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.13K Buy
+3,000
New +$7K ﹤0.01% 1331

Other funds holding XRTX

CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Kingsview Wealth Management's XRTX Position: Q1 2026 in Review

Kingsview Wealth Management opened a new position in XORTX Therapeutics (XRTX) in Q1 2026: 3,000 shares worth $6.13K. The stake represents ﹤0.01% of the portfolio and ranks #1331 among its holdings.

3 funds tracked by Wall St. Rank hold XRTX as of Q1 2026.

  • Kingsview Wealth Management held 3,000 shares of XORTX Therapeutics worth $6.13K as of Q1 2026.
  • XORTX Therapeutics was a new Kingsview Wealth Management position in Q1 2026.
  • XORTX Therapeutics made up ﹤0.01% of Kingsview Wealth Management's portfolio in Q1 2026, its #1331 holding.
  • 3 funds tracked by Wall St. Rank held XORTX Therapeutics as of Q1 2026.

Based on Kingsview Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.